Literature DB >> 35697854

Robotic spleen-preserving total gastrectomy shows better short-term advantages: a comparative study with laparoscopic surgery.

Zu-Kai Wang1,2, Jian-Xian Lin1,2,3, Fu-Hai Wang1,2, Jian-Wei Xie1,2,3, Jia-Bin Wang1,2,3, Jun Lu1,2, Qi-Yue Chen1,2, Long-Long Cao1,2, Mi Lin1,2, Ru-Hong Tu1,2, Ze-Ning Huang1,2, Ju-Li Lin1,2, Hua-Long Zheng1,2, Ping Li1,2,3, Chao-Hui Zheng1,2,3, Chang-Ming Huang4,5,6.   

Abstract

BACKGROUND: Robotic surgery may be advantageous for complex surgery. We aimed to compare the intraoperative and postoperative short-term outcomes of spleen-preserving splenic hilar lymphadenectomy (SPSHL) during robotic and laparoscopic total gastrectomy.
METHODS: From July 2016 to December 2020, the clinicopathological data of 115 patients who underwent robotic total gastrectomy combined with robotic SPSHL (RSPSHL) and 697 patients who underwent laparoscopic total gastrectomy combined with laparoscopic SPSHL (LSPSHL) were retrospectively analyzed. A 1:2 ratio propensity score matching (PSM) was used to balance the differences between the two groups to compare their outcomes. The Generic Error Rating Tool was used to evaluate the technical performance.
RESULTS: After PSM, the baseline preoperative characteristics of the 115 patients in the RSPSHL and 230 patients in the LSPSHL groups were balanced. The dissection time of the region of the splenic artery trunk (5.4 ± 1.9 min vs. 7.8 ± 3.6 min, P < 0.001), the estimated blood loss during SPSHL (9.6 ± 4.8 ml vs. 14.9 ± 7.8 ml, P < 0.001), and the average number of intraoperative technical errors during SPSHL (15.1 ± 3.4 times/case vs. 20.7 ± 4.3 times/case, P < 0.001) were significantly lower in the RSPSHL group than in the LSPSHL group. The RSPSHL group showed higher dissection rates of No. 10 (78.3% vs. 70.0%, P = 0.104) and No. 11d (54.8% vs. 40.4%, P = 0.012) lymph nodes and significantly improved postoperative recovery results in terms of times to ambulation, first flatus, and first intake (P < 0.05). The splenectomy rates of the two groups were similar (1.7% vs. 0.4%, P = 0.539), and there was no significant difference in morbidity and mortality within postoperative 30 days (13.0% vs. 15.2%, P = 0.589).
CONCLUSION: Compared to LSPSHL, RSPSHL has more advantages in terms of surgical qualities and postoperative recovery process with similar morbidity and mortality. For complex SPSHL, robotic surgery may be a better choice.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Advanced proximal gastric cancer; Laparoscopic surgery; Propensity score matching; Robotic surgery; Spleen-preserving splenic hilar lymphadenectomy

Year:  2022        PMID: 35697854     DOI: 10.1007/s00464-022-09352-1

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  47 in total

1.  Robot-assisted gastric surgery.

Authors:  Makoto Hashizume; Keizo Sugimachi
Journal:  Surg Clin North Am       Date:  2003-12       Impact factor: 2.741

2.  Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial.

Authors:  Jiang Yu; Changming Huang; Yihong Sun; Xiangqian Su; Hui Cao; Jiankun Hu; Kuan Wang; Jian Suo; Kaixiong Tao; Xianli He; Hongbo Wei; Mingang Ying; Weiguo Hu; Xiaohui Du; Yanfeng Hu; Hao Liu; Chaohui Zheng; Ping Li; Jianwei Xie; Fenglin Liu; Ziyu Li; Gang Zhao; Kun Yang; Chunxiao Liu; Haojie Li; Pingyan Chen; Jiafu Ji; Guoxin Li
Journal:  JAMA       Date:  2019-05-28       Impact factor: 56.272

3.  Robotic distal subtotal gastrectomy with D2 lymphadenectomy for gastric cancer patients with high body mass index: comparison with conventional laparoscopic distal subtotal gastrectomy with D2 lymphadenectomy.

Authors:  Juhan Lee; Yoo-Min Kim; Yanghee Woo; Kazutaka Obama; Sung Hoon Noh; Woo Jin Hyung
Journal:  Surg Endosc       Date:  2015-01-29       Impact factor: 4.584

4.  Long-term Comparison of Robotic and Laparoscopic Gastrectomy for Gastric Cancer: A Propensity Score-weighted Analysis of 2084 Consecutive Patients.

Authors:  Ho-Jung Shin; Sang-Yong Son; Bo Wang; Chul Kyu Roh; Hoon Hur; Sang-Uk Han
Journal:  Ann Surg       Date:  2021-07-01       Impact factor: 12.969

5.  Assessment of Robotic Versus Laparoscopic Distal Gastrectomy for Gastric Cancer: A Randomized Controlled Trial.

Authors:  Jun Lu; Chao-Hui Zheng; Bin-Bin Xu; Jian-Wei Xie; Jia-Bin Wang; Jian-Xian Lin; Qi-Yue Chen; Long-Long Cao; Mi Lin; Ru-Hong Tu; Ze-Ning Huang; Ju-Li Lin; Hua-Long Zheng; Chang-Ming Huang; Ping Li
Journal:  Ann Surg       Date:  2021-05-01       Impact factor: 12.969

6.  Laparoscopy-assisted Billroth I gastrectomy.

Authors:  S Kitano; Y Iso; M Moriyama; K Sugimachi
Journal:  Surg Laparosc Endosc       Date:  1994-04

7.  Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer: Short-term Outcomes From a Multicenter Randomized Controlled Trial (KLASS-01).

Authors:  Wook Kim; Hyung-Ho Kim; Sang-Uk Han; Min-Chan Kim; Woo Jin Hyung; Seung Wan Ryu; Gyu Seok Cho; Chan Young Kim; Han-Kwang Yang; Do Joong Park; Kyo Young Song; Sang Il Lee; Seung Yub Ryu; Joo-Ho Lee; Hyuk-Joon Lee
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

8.  Multidimensional learning curve in laparoscopy-assisted gastrectomy for early gastric cancer.

Authors:  Sung-Ho Jin; Do-Yoon Kim; Hong Kim; In Ho Jeong; Myung-Wook Kim; Yong Kwan Cho; Sang-Uk Han
Journal:  Surg Endosc       Date:  2006-09-06       Impact factor: 4.584

9.  Robot-assisted laparoscopic total and partial gastric resection with D2 lymph node dissection for adenocarcinoma.

Authors:  Alberto Patriti; Graziano Ceccarelli; Raffaele Bellochi; Alberto Bartoli; Alessandro Spaziani; Lelio Di Zitti; Luciano Casciola
Journal:  Surg Endosc       Date:  2008-09-24       Impact factor: 4.584

10.  Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage II/III Gastric Cancer: A Multicenter Cohort Study in Japan (LOC-A Study).

Authors:  Takahiro Kinoshita; Ichiro Uyama; Masanori Terashima; Hirokazu Noshiro; Eishi Nagai; Kazutaka Obama; Yutaka Tamamori; Toshinaga Nabae; Michitaka Honda; Takayuki Abe
Journal:  Ann Surg       Date:  2019-05       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.